Immunotherapy Offers Bladder Cancer Option
An advanced clinical study has revealed that a new immunotherapy helps high-risk bladder cancer patients avoid bladder removal after standard treatment failure. Sixty-one percent of participants did not require surgery after two years, and 75% of them experienced complete remission with total disappearance of the cancer. This treatment offers a safe alternative to surgery, contributing to the preservation of patients' quality of life, and shows promising results in reducing the need for bladder removal without increasing side effects.
Size: 120%Text Size
Notice: This Is an AI-Generated Summary
Comments (0)